Stocks and Investing Stocks and Investing
Thu, September 7, 2023

Joseph Pantginis Reiterated (ATNM) at Strong Buy and Held Target at $50 on, Sep 7th, 2023


Published on 2024-10-28 06:18:14 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy and Held Target at $50 on, Sep 7th, 2023.

Joseph has made no other calls on ATNM in the last 4 months.



There is 1 other peer that has a rating on ATNM. Out of the 1 peers that are also analyzing ATNM, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $12 on, Wednesday, September 6th, 2023
Contributing Sources